Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
EU Approval Decision Delay For BMS’s Ozanimod
Company Needed More Time To Answer Questions On New MS Product
Mar 06 2020
•
By
Maureen Kenny
Companies sometime ask for extra time to address regulators' questions • Source: Shutterstock
More from Europe
More from Geography